BIODESIX, INC. Capital Expenditures
BIODESIX, INC. (BDSX) reported Capital Expenditures of $278.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- BIODESIX, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $197.00K, a 286.27% increase year-over-year.
- BIODESIX, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $81.00K, a 9.46% increase year-over-year.
- BIODESIX, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $86.00K, a 89.75% decline year-over-year.
- BIODESIX, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $48.00K, a 79.22% decline year-over-year.
- BIODESIX, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $259.00K, a 91.98% decline from fiscal 2024.
- BIODESIX, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $3.23M, a 85.91% decline from fiscal 2023.
- BIODESIX, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $22.92M, a 594.94% increase from fiscal 2022.
- BIODESIX, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $3.30M, a 47.17% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $278.00K 10-Q · filed 2026-08-05 | $364.00K derived: sum of 3 quarters · filed 2026-08-05 | $412.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $81.00K 10-Q · filed 2026-05-04 | $167.00K derived: sum of 2 quarters · filed 2026-05-04 | $215.00K derived: sum of 3 quarters · filed 2026-05-04 | $266.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $134.00K derived: sum of 2 quarters · filed 2026-02-26 | $185.00K derived: sum of 3 quarters · filed 2026-08-05 | $259.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $99.00K derived: sum of 2 quarters · filed 2026-08-05 | $173.00K 10-Q · filed 2025-11-03 | $1.01M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $125.00K 10-Q · filed 2026-08-05 | $964.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $74.00K 10-Q · filed 2026-05-04 | $913.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.14M derived: sum of 3 quarters · filed 2026-05-04 | $3.07M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $839.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.07M derived: sum of 2 quarters · filed 2026-02-26 | $3.00M derived: sum of 3 quarters · filed 2026-02-26 | $3.23M 10-K · filed 2026-02-26 |
| 2024-09-30 | $231.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $2.16M derived: sum of 2 quarters · filed 2025-11-03 | $2.39M 10-Q · filed 2025-11-03 | $5.38M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.16M 10-Q · filed 2025-08-07 | $5.14M derived: sum of 3 quarters · filed 2025-08-07 | $10.99M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $234.00K 10-Q · filed 2025-05-13 | $3.22M derived: sum of 2 quarters · filed 2025-05-13 | $9.06M derived: sum of 3 quarters · filed 2025-05-13 | $15.48M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $8.83M derived: sum of 2 quarters · filed 2025-03-03 | $15.24M derived: sum of 3 quarters · filed 2025-03-03 | $22.92M 10-K · filed 2025-03-03 |
| 2023-09-30 | $5.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $12.26M derived: sum of 2 quarters · filed 2024-11-01 | $19.93M 10-Q · filed 2024-11-01 | $21.86M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $6.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $14.09M 10-Q · filed 2024-08-07 | $16.02M derived: sum of 3 quarters · filed 2024-08-07 | $16.80M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $7.68M 10-Q · filed 2024-05-08 | $9.61M derived: sum of 2 quarters · filed 2024-05-08 | $10.38M derived: sum of 3 quarters · filed 2024-05-08 | $10.71M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $2.71M derived: sum of 2 quarters · filed 2024-03-01 | $3.04M derived: sum of 3 quarters · filed 2024-03-01 | $3.30M 10-K · filed 2024-03-01 |
| 2022-09-30 | $777.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.11M derived: sum of 2 quarters · filed 2023-11-07 | $1.37M 10-Q · filed 2023-11-07 | $1.90M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $591.00K 10-Q · filed 2023-08-07 | $1.12M derived: sum of 3 quarters · filed 2023-08-07 | $2.08M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $262.00K 10-Q · filed 2023-05-11 | $792.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.76M derived: sum of 3 quarters · filed 2023-05-11 | $2.04M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $530.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $1.49M derived: sum of 2 quarters · filed 2023-03-06 | $1.77M derived: sum of 3 quarters · filed 2023-03-06 | $2.24M 10-K · filed 2023-03-06 |
| 2021-09-30 | $964.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.25M derived: sum of 2 quarters · filed 2022-11-03 | $1.71M 10-Q · filed 2022-11-03 | $2.17M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $281.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $747.00K 10-Q · filed 2022-08-04 | $1.21M derived: sum of 3 quarters · filed 2022-08-04 | $2.46M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $466.00K 10-Q · filed 2022-05-11 | $928.00K derived: sum of 2 quarters · filed 2022-05-11 | $2.18M derived: sum of 3 quarters · filed 2022-05-11 | $2.31M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.71M derived: sum of 2 quarters · filed 2022-03-14 | $1.85M derived: sum of 3 quarters · filed 2022-03-14 | $1.95M 10-K · filed 2022-03-14 |
| 2020-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.39M derived: sum of 2 quarters · filed 2021-11-15 | $1.48M 10-Q · filed 2021-11-15 | $1.88M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $232.00K 10-Q · filed 2021-08-10 | $627.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $98.00K 10-Q · filed 2021-05-11 | $493.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $1.31M 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $915.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |